LASS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.900600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.703000E-01
Normal-vs-Stage2
4.695800E-01
Normal-vs-Stage3
7.899600E-01
Normal-vs-Stage4
3.019800E-01
Stage1-vs-Stage2
6.562000E-01
Stage1-vs-Stage3
3.504800E-01
Stage1-vs-Stage4
6.141800E-01
Stage2-vs-Stage3
1.694760E-01
Stage2-vs-Stage4
2.040800E-01
Stage3-vs-Stage4
1.508990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.373000E-01
Normal-vs-AfricanAmerican
1.641600E-01
Normal-vs-Asian
5.221400E-01
Caucasian-vs-AfricanAmerican
7.559900E-02
Caucasian-vs-Asian
9.812000E-01
AfricanAmerican-vs-Asian
6.727900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.135800E-01
Normal-vs-Female
6.242600E-01
Male-vs-Female
6.352100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.421600E-01
Normal-vs-Age(41-60Yrs)
2.480400E-01
Normal-vs-Age(61-80Yrs)
6.028600E-01
Normal-vs-Age(81-100Yrs)
6.713800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.167040E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.923400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.625200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.802300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.073000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.565600E-01
Normal-vs-Daily Drinker
9.300800E-01
Normal-vs-Weekly Drinker
3.266600E-01
Normal-vs-Occasional Drinker
2.160200E-01
Normal-vs-Social Drinker
8.298400E-01
Non Drinker-vs-Daily Drinker
5.044000E-01
Non Drinker-vs-Weekly Drinker
2.852400E-01
Non Drinker-vs-Occasional Drinker
2.148600E-01
Non Drinker-vs-Social Drinker
6.778400E-01
Daily Drinker-vs-Weekly Drinker
1.576820E-01
Daily Drinker-vs-Occasional Drinker
8.506000E-02
Daily Drinker-vs-Social Drinker
7.105400E-01
Weekly Drinker-vs-Occasional Drinker
9.891000E-01
Weekly Drinker-vs-Social Drinker
1.238410E-01
Occasional Drinker-vs-Social Drinker
5.829900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.261500E-02
Normal-vs-Grade 2
8.060000E-03
Normal-vs-Grade 3
3.136400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.795000E-01
Grade 1-vs-Grade 3
2.645200E-01
Grade 1-vs-Grade 4
5.261500E-02
Grade 2-vs-Grade 3
8.947400E-01
Grade 2-vs-Grade 4
8.060000E-03
Grade 3-vs-Grade 4
3.136400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.409200E-01
Normal-vs-NonDiabetic
3.712600E-01
Diabetic-vs-NonDiabetic
1.302180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.131600E-01
Normal-vs-NoPancreatitis
5.491200E-01
Pancreatitis-vs-NoPancreatitis
3.807200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.466600E-01
Normal-vs-N1
5.317200E-01
N0-vs-N1
1.852780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.536300E-02
Normal-vs-TP53-NonMutant
4.669000E-01
TP53-Mutant-vs-TP53-NonMutant
8.138900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
